Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24298917.
- Also identified by DOI 10.1111/bju.12593 and PMC identifier 4568118.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prostate MRI is currently the best diagnostic imaging method for detecting PCa. Magnetic resonance imaging (MRI)/ultrasonography (US) fusion allows the sensitivity and specificity of MRI to be combined with the real-time capabilities of transrectal ultrasonography (TRUS). Multiple approaches and techniques exist for MRI/US fusion and include direct 'in bore' MRI biopsies, cognitive fusion, and MRI/US fusion via software-based image coregistration platforms.
Medical subject headings
- Image-Guided Biopsy
- Magnetic Resonance Imaging
- Prostate
- Prostatic Neoplasms
- Ultrasonography